The German pharmaceutical-and-agricultural group said the acquisition would complement its drug pipeline and leverage its ...
21 June 2024, Berlin: Stefan Oelrich, member of the Board of Management of Bayer AG, speaks at the project presentation of the Translational Center for Gene and Cell Therapies of Charité and Bayer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results